Activity of the PARP inhibitor olaparib in ATM-deficient gastric cancer: from preclinical models to the clinicD. Hodgson,H. Mason,L. Oplustilova,C. Harbron,X. Yin,S. A. Im,H. Jones,L. Zhongwu,B. Dougherty,M. McLoughlin,A. Dickinson,A. Fielding,J. Robertson,W. H. Kim,C. Womack,Y. Gu,Y. J. Bang,A. Lau,J. C. Barrett,M. J. O'ConnorEuropean Journal of Cancer(2014)引用 4|浏览32暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要